Skip to main content
FinSpry Logo
FinSpry
RARE logo
RARE
(NASDAQ)
Ultragenyx Pharmaceutical Inc.
$28.76-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ultragenyx Pharmaceutical (RARE) Stock Price & Financial Analysis

Ultragenyx Pharmaceutical Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.50 - $29.39
52-Week High$42.37
52-Week Low$18.29
Open$28.58
Volume2.04M
Average Volume (3M)1.75M
Market Cap2.89B
Shares Outstanding100.60M
Price to Sales (P/S)4.36
Price to Book (P/B)-12.37
EV/EBITDA-7.85
Revenue (TTM)669.71M
Net Income (TTM)-608.92M
Free Cash Flow (TTM)-505.85M
EPS (TTM)$-6.11
Profit Margin-90.92%
Operating Margin-83.78%
50-Day MA$24.42
200-Day MA$27.02
52-Week Change-21.84%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ultragenyx Pharmaceutical

What is the current stock price for RARE?

As of the latest trading session, RARE stock trades at $28.76. The 52-week range is $18.29–$42.37, with a day range of $28.50–$29.39.

What is the P/E ratio for RARE?

The P/E ratio (Price-to-Earnings) for RARE is shown in the Key Statistics section. This valuation metric helps compare Ultragenyx Pharmaceutical Inc. to industry peers.

Does RARE pay dividends?

Ultragenyx Pharmaceutical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RARE?

Based on 16 analysts, the consensus for RARE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RARE?

Ultragenyx Pharmaceutical's market capitalization is $2.89B, classifying it as a mid-cap company. Ultragenyx Pharmaceutical operates in the Healthcare sector within the Biotechnology industry.